Cargando…
Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
The interleukin-23 [IL-23] cytokine, derived predominantly from macrophages and dendritic cells in response to microbial stimulation, has emerged as a critical promoter of chronic intestinal inflammation. Genome-wide association studies linking variants in IL23R to disease protection, bolstered by e...
Autores principales: | Sewell, Gavin W, Kaser, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097674/ https://www.ncbi.nlm.nih.gov/pubmed/35553667 http://dx.doi.org/10.1093/ecco-jcc/jjac034 |
Ejemplares similares
-
Interleukin-23 in perspective
por: Sherlock, Jonathan P, et al.
Publicado: (2021) -
The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease
por: Graff, Lesley A, et al.
Publicado: (2023) -
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023) -
The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease
por: Korta, Aleksandra, et al.
Publicado: (2023) -
The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease
por: Targownik, Laura E, et al.
Publicado: (2023)